Breaking News Instant updates and real-time market news.

AMRX

Amneal Pharmaceuticals

$17.76

0.12 (0.68%)

, ANIP

ANI Pharmaceuticals

$70.75

-0.615 (-0.86%)

11:13
07/10/18
07/10
11:13
07/10/18
11:13

FTC approves final order imposing conditions on merger of Amneal with Impax

The Federal Trade Commission announced that it has approved a final order settling charges that Amneal's (AMRX) $1.45B acquisition of an equity share in Impax likely would be anticompetitive. Under the settlement, ANI Pharmaceuticals, (ANIP) will acquire seven products. Perrigo (PRGO) will acquire Impax's rights to two products that it had partnered with Impax to develop, manufacture, and sell. G&W Laboratories will acquire Impax's marketing rights to one product that G&W manufactures for Impax. Reference Link

AMRX

Amneal Pharmaceuticals

$17.76

0.12 (0.68%)

ANIP

ANI Pharmaceuticals

$70.75

-0.615 (-0.86%)

PRGO

Perrigo

$77.35

-0.18 (-0.23%)

  • 09

    Aug

AMRX Amneal Pharmaceuticals
$17.76

0.12 (0.68%)

05/18/18
05/18/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MasterCard (MA) initiated with a Neutral at UBS. 2. AMD (AMD) initiated with an Outperform at Cowen while Intel (INTC) was initiated with a Market Perform. 3. Synthetic Biologics (SYN) initiated with a Buy at H.C. Wainwright. 4. Amneal Pharmaceuticals (AMRX) initiated with a Neutral at JPMorgan. 5. Apollo Commercial (ARI) initiated with a Buy at Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/18/18
JPMS
05/18/18
INITIATION
Target $18
JPMS
Neutral
Amneal Pharmaceuticals initiated with a Neutral at JPMorgan
JPMorgan analyst Chris Schott started Amneal Pharmaceuticals with a Neutral rating and $18 price target. The company is well positioned within the generics space, but its valuation trades at a premium to peers, Schott tells investors in a research note. He also notes the company's 2018 guidance requires a "significant step up" in EBITDA from Q1 levels based on a heavy cycle of upcoming pipeline launches.
05/09/18
05/09/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Cleveland-Cliffs (CLF) initiated with a Buy at Seaport Global. 2. Amneal Pharmaceuticals (AMRX) initiated with a Buy at Deutsche Bank. 3. Iridium (IRDM) initiated with a Buy at BWS Financial. 4. ServiceMaster (SERV) initiated with a Buy at Buckingham while Rollins (ROL) was initiated with a Neutral at Buckingham. 5. Eiger BioPharmaceuticals (EIGR) initiated with a Buy at B. Riley FBR. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/22/18
RILY
06/22/18
INITIATION
Target $26
RILY
Buy
Amneal Pharmaceuticals initiated with a Buy at B. Riley FBR
B. Riley FBR analyst David Buck started Amneal Pharmaceuticals with a Buy rating and $26 price target. The merger of two niche generic companies created a new generic leader, Buck tells investors in a research note.
ANIP ANI Pharmaceuticals
$70.75

-0.615 (-0.86%)

10/16/17
ADAM
10/16/17
NO CHANGE
Target $66
ADAM
Buy
ANI Pharmaceuticals could sell itself for $70 a share, says Canaccord
Canaccord analyst Dewy Steadman commented on the reports ANI Pharmaceuticals was in talks to sell itself. He believes the company could be an attractive asset to a number of different acquirers for a number of different reasons and believes it could warrant $70 a share in a takeout. The analyst said even in the absence of a sale, he remains positive as its business is differentiated from larger peers. Steadman reiterated his Buy rating on ANI Pharmaceuticals shares.
01/02/18
ADAM
01/02/18
NO CHANGE
Target $77
ADAM
Buy
ANI Pharmaceuticals best positioned in emerging generics space, says Canaccord
Canaccord analyst Dewey Steadman said ANI Pharmaceuticals (ANIP) is one of the best positioned names in the emerging generics space. He noted the company has a basket of additional branded tail assets from its AstraZeneca (AZN) acquisitions, additional cash on hand and credit facilities for future transactions, and a solid core business. Steadman reiterated his Buy rating and raised his price target to $77 from $75 on ANI Pharmaceuticals shares.
06/12/18
CANT
06/12/18
INITIATION
CANT
Cantor expands Specialty Pharmaceuticals coverage with eight names
Cantor Fitzgerald analyst Brandon Folkes last night rolled out coverage on eight names in the Specialty Pharmaceuticals space. He initiated coverage of AcelRx (ACRX), ANI Pharmaceuticals (ANIP), Biohaven Pharmaceutical (BHVN), Collegium Pharmaceutical (COLL), Emergent BioSolutions (EBS), Eagle Pharmaceuticals (EGRX) and Opiant Pharmaceuticals (OPNT) with Overweight ratings. There is still value to be unlocked in these stocks at current valuations with risk/reward profiles that remain to the upside, Folkes told investors in a research note. His top picks are ANI Pharmaceuticals, Emergent BioSolutions and Collegium Pharmaceutical. The analyst rounded out his coverage with a Neutral rating on Momenta (MNTA), saying the recent share rally puts him on the sidelines "for now."
06/11/18
CANT
06/11/18
INITIATION
Target $85
CANT
Overweight
ANI Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald
Cantor initiated ANI Pharmaceuticals with a Overweight and $85 price target.
PRGO Perrigo
$77.35

-0.18 (-0.23%)

06/18/18
MSCO
06/18/18
NO CHANGE
Target $85
MSCO
Equal Weight
Perrigo price target lowered to $85 from $92 at Morgan Stanley
Morgan Stanley analyst David Risinger lowered his annual EPS estimates for Perrigo, primarily due to a delay in the launch of generic ProAir, stating that he now assumes a launch in October of next year instead of in October of this year. He also reduced his Q2 estimates due to expectations for flattish generic segment performance and lowered his price target on the stock to $85. Risinger maintains an Equal Weight rating on Perrigo shares.
05/14/18
WELS
05/14/18
NO CHANGE
Target $84
WELS
Market Perform
Perrigo price target lowered to $84 from $90 at Wells Fargo
Wells Fargo analyst David Maris lowered his price target for Perrigo to $84 from $90 following the news that the company now expects to receive a complete response letter from the FDA on its generic ProAir filing and that Perrigo no longer expects an approval of its ProAir generic to be a 2018 event. The analyst reiterates Market Perform rating on the shares.
05/15/18
ADAM
05/15/18
NO CHANGE
Target $105
ADAM
Buy
Perrigo ProAir setback disappointing but thesis intact, says Canaccord
Canaccord analyst Dewey Steadman said the delay of Perrigo's generic ProAir is disappointing, but the company's diversification keeps the thesis intact. The analyst said he was impressed with the speed of disclosure of the expected CRL, but he believes the drug will not be coming in Q4 as expected. He has adjusted his model for a 2020 launch and has faith in the company's ability to deliver and grow revenues. Steadman reiterated his Buy rating and $105 price target on Perrigo shares.
06/06/18
LEHM
06/06/18
DOWNGRADE
Target $80
LEHM
Equal Weight
Perrigo downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Douglas Tsao downgraded Perrigo to Equal Weight and lowered his price target for the shares to $80 from $93. The company's inability to win approval for its generic version of ProAir reduces near-term earnings momentum, Tsao tells investors in a research note. The analyst feels it will be hard for investors to get comfortable with Perrigo's long-term outlook given secular changes in over-the-counter space.

TODAY'S FREE FLY STORIES

PLT

Plantronics

$76.03

-1.03 (-1.34%)

09:32
07/19/18
07/19
09:32
07/19/18
09:32
Periodicals
Plantronics mentioned cautiously by Seeking Alpha contributor 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGG

Briggs & Stratton

$17.71

0.235 (1.34%)

09:30
07/19/18
07/19
09:30
07/19/18
09:30
Downgrade
Briggs & Stratton rating change  »

Briggs & Stratton…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
07/19/18
07/19
09:30
07/19/18
09:30
General news
Breaking General news story  »

Week of 7/15 Bloomberg…

SQ

Square

$68.30

-0.02 (-0.03%)

09:29
07/19/18
07/19
09:29
07/19/18
09:29
Recommendations
Square analyst commentary  »

Square price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 15

    Aug

  • 16

    Aug

FITB

Fifth Third

$30.26

0.75 (2.54%)

09:29
07/19/18
07/19
09:29
07/19/18
09:29
Hot Stocks
Fifth Third sees Q3 NIM flat from Q2 »

Says expects to achieve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

BA

Boeing

$360.23

3.28 (0.92%)

09:28
07/19/18
07/19
09:28
07/19/18
09:28
Hot Stocks
Boeing announces $100B in orders and commitments at Farnborough Airshow »

Boeing strengthened its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

PM

Philip Morris

$82.16

-0.17 (-0.21%)

09:27
07/19/18
07/19
09:27
07/19/18
09:27
Hot Stocks
Breaking Hot Stocks news story on Philip Morris »

Philip Morris cuts FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

UAL

United Continental

$79.02

6.355 (8.75%)

09:27
07/19/18
07/19
09:27
07/19/18
09:27
Recommendations
United Continental analyst commentary  »

United Continental price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$82.16

-0.17 (-0.21%)

09:27
07/19/18
07/19
09:27
07/19/18
09:27
Earnings
Philip Morris sees Q3 net revenue up about 1% ex-currency, consensus $7.87B »

Sees net revenue decline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

PM

Philip Morris

$82.16

-0.17 (-0.21%)

09:25
07/19/18
07/19
09:25
07/19/18
09:25
Hot Stocks
Philip Morris CFO says IQOS tracking below initial expectations for 2018 »

Says plans to introduce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

09:25
07/19/18
07/19
09:25
07/19/18
09:25
Conference/Events
UBS European oil and gas analyst to hold an analyst/industry conference call »

European Oil & Gas…

TYL

Tyler Technologies

$237.74

0.33 (0.14%)

09:22
07/19/18
07/19
09:22
07/19/18
09:22
Hot Stocks
Tyler Technologies announces agreement with city of Atlanta for EnerGov »

Tyler Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 04

    Sep

NCLH

Norwegian Cruise Line

$50.15

2.565 (5.39%)

09:22
07/19/18
07/19
09:22
07/19/18
09:22
Recommendations
Norwegian Cruise Line analyst commentary  »

Norwegian Cruise Line…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHLB

Berkshire Hills Bancorp

$40.80

0.15 (0.37%)

09:22
07/19/18
07/19
09:22
07/19/18
09:22
Upgrade
Berkshire Hills Bancorp rating change  »

Berkshire Hills Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

BPMX

BioPharmX

$0.20

-0.0006 (-0.30%)

09:21
07/19/18
07/19
09:21
07/19/18
09:21
Hot Stocks
BioPharmX granted CARC waiver by FDA for acne candidate BPX-01 »

BioPharmX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:20
07/19/18
07/19
09:20
07/19/18
09:20
General news
Fed's Quarles said the implementation of SOFR »

Fed's Quarles said…

GWW

Grainger

$338.99

33.78 (11.07%)

09:18
07/19/18
07/19
09:18
07/19/18
09:18
Recommendations
Grainger analyst commentary  »

Grainger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
07/19/18
07/19
09:18
07/19/18
09:18
Options
Overnight activity included 163 trades in SPX and 5 trades in VIX »

163 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FITB

Fifth Third

$30.26

0.75 (2.54%)

09:16
07/19/18
07/19
09:16
07/19/18
09:16
Hot Stocks
Fifth Third sees FY18 tax rate 16%-16.5% »

Says second half net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

VRS

Verso

$21.21

-0.01 (-0.05%)

09:16
07/19/18
07/19
09:16
07/19/18
09:16
Recommendations
Verso analyst commentary  »

Verso should be owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

D

Dominion

$69.96

-0.42 (-0.60%)

, DM

Dominion Midstream

$13.65

-0.05 (-0.36%)

09:15
07/19/18
07/19
09:15
07/19/18
09:15
Hot Stocks
Dominion Midstream jumps after FERC modifies gas pipeline tax law-related rule »

Shares of Dominion Energy…

D

Dominion

$69.96

-0.42 (-0.60%)

DM

Dominion Midstream

$13.65

-0.05 (-0.36%)

AMID

American Midstream Partners

$11.55

1.025 (9.74%)

ANDX

Andeavor Logistics

$43.20

0.99 (2.35%)

AMGP

Antero Midstream GP

$18.67

0.03 (0.16%)

AM

Antero Midstream Partners

$30.84

0.9 (3.01%)

APLP

Archrock Partners LP

$0.00

(0.00%)

BKEP

Blueknight Energy Partners

$3.00

-0.15 (-4.76%)

BWP

Boardwalk Pipeline

$0.00

(0.00%)

BPL

Buckeye Partners

$33.23

-1.725 (-4.94%)

CQP

Cheniere Energy Partners

$36.46

0.71 (1.99%)

CNXM

CNX Midstream Partners

$19.37

0.14 (0.73%)

CEQP

Crestwood Equity

$34.20

0.7 (2.09%)

CCLP

CSI Compressco

$5.57

0.1 (1.83%)

DCP

DCP Midstream

$42.40

0.58 (1.39%)

DKL

Delek Logistics

$28.10

0.2 (0.72%)

ENBL

Enable Midstream

$18.30

0.52 (2.92%)

EEQ

Enbridge Energy Management

$10.12

-0.08 (-0.78%)

EEP

Enbridge Energy

$10.57

-0.1 (-0.94%)

ETP

Energy Transfer Partners

$19.40

0.135 (0.70%)

ETE

Energy Transfer Equity

$17.16

0.07 (0.41%)

ENLC

EnLink Midstream

$15.60

0.3 (1.96%)

ENLK

EnLink Midstream Partners

$15.44

0.52 (3.49%)

EPD

Enterprise Products

$28.65

0.43 (1.52%)

EQM

EQT Midstream Partners

$55.18

1.245 (2.31%)

MMLP

Martin Midstream Partners

$13.50

-0.05 (-0.37%)

MMP

Magellan Midstream

$68.03

0.58 (0.86%)

MPLX

MPLX

$34.85

1.33 (3.97%)

NGL

NGL Energy Partners

$12.60

0.4 (3.28%)

NBLX

Noble Midstream

$51.22

0.13 (0.25%)

NS

NuStar Energy

$24.84

0.4 (1.64%)

SHLX

Shell Midstream

$22.93

0.61 (2.73%)

TEGP

Tallgrass Energy GP

$0.00

(0.00%)

TEP

Tallgrass Energy Partners

$0.00

(0.00%)

TLP

TransMontaigne

$39.66

0.77 (1.98%)

VLP

Valero Energy Partners

$38.91

0.17 (0.44%)

WES

Western Gas Partners

$49.45

0.835 (1.72%)

WPZ

Williams Partners

$41.92

1.35 (3.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 01

    Aug

  • 01

    Aug

  • 01

    Aug

  • 01

    Aug

  • 01

    Aug

  • 02

    Aug

  • 02

    Aug

  • 02

    Aug

  • 03

    Aug

  • 03

    Aug

  • 03

    Aug

  • 08

    Aug

  • 08

    Aug

  • 01

    Oct

  • 07

    Nov

09:15
07/19/18
07/19
09:15
07/19/18
09:15
General news
U.S. equities were dented with global stocks »

U.S. equities were dented…

GWW

Grainger

$338.99

33.78 (11.07%)

09:14
07/19/18
07/19
09:14
07/19/18
09:14
Recommendations
Grainger analyst commentary  »

Grainger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMTC

Bryn Mawr Bank

$47.20

0.35 (0.75%)

09:13
07/19/18
07/19
09:13
07/19/18
09:13
Hot Stocks
Bryn Mawr Bank raises quarterly dividend 13.6% to 25c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$60.51

-0.66 (-1.08%)

09:13
07/19/18
07/19
09:13
07/19/18
09:13
Hot Stocks
T-Mobile launches NB-IoT nationwide »

T-Mobile launched its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.